Bluebird Sickle Cell Gene Therapy Ends Painful Attacks for Some

(Bloomberg) -- A single infusion of Bluebird Bio Inc.’s gene therapy for sickle cell disease eliminated serious pain crises and the need for red blood cell transfusions in a small study of patients...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.